The epidemiology of ventricular tachycardia/fibrillation (VT/VF) and s
udden cardiac death (SCD) must be explored from multiple aspects, each
of which contributes insights into the problem and no one of which ex
erts exclusive dominance for preventive or therapeutic strategies. The
se include: (1) population dynamics, using conventional epidemiologic
approaches; (2) risk as a function of time from an index event; (3) co
nditioning risk factors, based on the presence of underlying disease s
tates; (4) transient risk factors that are dynamic and trigger a poten
tially fatal event at a specific point in time; and (5) ''response ris
k,'' which refers to individual susceptibility (possibly determined ge
netically) to the adverse effects of longitudinal and/or dynamic risk
factors. Major inroads into profiling individual or population risk of
SCD will require better understanding of each of these epidemiologic-
clinical-physiologic interactions. The disciplines range from epidemio
logy, through clinical medicine, to membrane channel physiology, genet
ic determinants, and molecular biology. (C) 1997 by Excerpta Medica, I
nc.